Listed

Rigel Pharmaceuticals Inc

RIGLNasdaqCIK 1034842HealthcareFiscal year ends Dec 31

Reports and events: 282 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Rigel Pharmaceuticals Inc, Reports and events
FiledFormWhat it isAccession number
2023-11-0716:05 ET10-QQuarterly reportPeriod 2023-09-300001558370-23-017987
2023-08-0116:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-086368
2023-08-0116:05 ET10-QQuarterly reportPeriod 2023-06-300001558370-23-012722
2023-05-3016:00 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001104659-23-065988
2023-05-0216:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-055028
2023-05-0216:06 ET10-QQuarterly reportPeriod 2023-03-310001558370-23-007653
2023-04-1408:03 ETDEF 14AProxy statement0001140361-23-018393
2023-03-0716:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-029558
2023-03-0716:05 ET10-KAnnual reportPeriod 2022-12-310001558370-23-003035
2023-02-0316:31 ET8-K5.02 Departure or appointment of officers or directors0001104659-23-010536
2023-01-0908:10 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-23-002074
2022-12-0206:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-123853
2022-11-2916:05 ET8-K3.01 Delisting notice0001104659-22-122864
2022-11-0316:25 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-016266
2022-11-0316:05 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-22-114413
2022-11-0116:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-113463
2022-10-1116:15 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-107725
2022-08-0216:11 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-22-085188
2022-08-0216:07 ET10-QQuarterly reportPeriod 2022-06-300001558370-22-011638
2022-07-2517:12 ET8-K8.01 Other events0001104659-22-082470
2022-06-2316:15 ET8-K8.01 Other events0001104659-22-073906
2022-06-0816:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-069317
2022-05-2316:52 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001104659-22-063899
2022-05-0316:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-055272
2022-05-0316:08 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-006809
2022-04-0516:35 ETDEF 14AProxy statementPeriod 2022-05-190001140361-22-013177
2022-03-0116:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-028673
2022-03-0116:06 ET10-KAnnual reportPeriod 2021-12-310001558370-22-002551
2022-02-1716:30 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001104659-22-024757
2022-01-2816:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-22-008984
2022-01-1008:40 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-002534
2021-12-1716:40 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-151192
2021-11-1509:00 ET8-K2.05 Exit or disposal costs0001104659-21-138665
2021-11-0216:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-132987
2021-11-0216:02 ET10-QQuarterly reportPeriod 2021-09-300001558370-21-014076
2021-08-1316:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-105111
2021-08-0316:26 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-099471
2021-08-0316:03 ET10-QQuarterly reportPeriod 2021-06-300001558370-21-009976
2021-05-2116:00 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001104659-21-070459
2021-05-1409:00 ET8-K5.02 Departure or appointment of officers or directors0001104659-21-066458
2021-05-0516:02 ET10-QQuarterly reportPeriod 2021-03-310001558370-21-005903
2021-05-0516:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-061696
2021-04-1317:26 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-049830
2021-04-0617:28 ETDEF 14AProxy statementPeriod 2021-05-180001104659-21-047180
2021-03-0216:05 ET10-KAnnual reportPeriod 2020-12-310001558370-21-002254
2021-03-0216:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-030711
2021-02-1806:30 ET8-K1.01 Entry into a material agreement0001104659-21-025010
2021-02-0316:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-21-011506
2021-01-1116:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-002993
2020-11-0516:05 ET10-QQuarterly reportPeriod 2020-09-300001558370-20-012838

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:09 ET. Listed shows no prices and gives no investment advice.